FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386704991> ?p ?o ?g. }

• W4386704991 abstract "Cefmetazole is active against extended-spectrum β-lactamase-producing Escherichia coli (ESBLEC) and is a potential candidate for carbapenem-sparing therapy. This multicenter, observational study included patients hospitalized for invasive urinary tract infection due to ESBLEC between March 2020 and November 2021 at 10 facilities in Japan, for whom either cefmetazole or meropenem was initiated as a definitive therapy within 96 h of culture collection and continued for at least 3 d. Outcomes included clinical and microbiological effectiveness, recurrence within 28 d, and all-cause mortality (14 d, 30 d, in-hospital). Outcomes were adjusted for the inverse probability of propensity scores for receiving cefmetazole or meropenem. Eighty-one and forty-six patients were included in the cefmetazole and meropenem groups, respectively. Bacteremia accounted for 43% of the cefmetazole group, and 59% of the meropenem group. The crude clinical effectiveness, 14 d, 30 d, and in-hospital mortality for patients in the cefmetazole and meropenem groups were 96.1% vs 90.9%, 0% vs 2.3%, 0% vs 12.5%, and 2.6% vs 13.3%, respectively. After propensity score adjustment, clinical effectiveness, the risk of in-hospital mortality, and the risk of recurrence were similar between the two groups (P = 0.54, P = 0.10, and P = 0.79, respectively). In all cases with available data (cefmetazole : n = 61, meropenem : n = 22), both drugs were microbiologically effective. In all isolates, blaCTX-M was detected as the extended-spectrum β-lactamase gene. The predominant CTX-M subtype was CTX-M-27 (47.6%). Cefmetazole showed clinical and bacteriological effectiveness comparable to meropenem against invasive urinary tract infection due to ESBLECs." @default.
• W4386704991 created "2023-09-14" @default.
• W4386704991 creator A5002303307 @default.
• W4386704991 creator A5004871899 @default.
• W4386704991 creator A5006534529 @default.
• W4386704991 creator A5007757700 @default.
• W4386704991 creator A5008639301 @default.
• W4386704991 creator A5022751311 @default.
• W4386704991 creator A5025336363 @default.
• W4386704991 creator A5043849320 @default.
• W4386704991 creator A5051481287 @default.
• W4386704991 creator A5058736163 @default.
• W4386704991 creator A5067354013 @default.
• W4386704991 creator A5067747157 @default.
• W4386704991 creator A5079221259 @default.
• W4386704991 creator A5079585400 @default.
• W4386704991 creator A5081203939 @default.
• W4386704991 creator A5085225502 @default.
• W4386704991 creator A5088044766 @default.
• W4386704991 date "2023-09-13" @default.
• W4386704991 modified "2023-10-18" @default.
• W4386704991 title "Effectiveness of cefmetazole versus meropenem for invasive urinary tract infections caused by extended-spectrum β-lactamase-producing <i>Escherichia coli</i>" @default.
• W4386704991 cites W1550111394 @default.
• W4386704991 cites W1945945803 @default.
• W4386704991 cites W1981502817 @default.
• W4386704991 cites W2007708769 @default.
• W4386704991 cites W2030273248 @default.
• W4386704991 cites W2134906113 @default.
• W4386704991 cites W2162546139 @default.
• W4386704991 cites W2196303878 @default.
• W4386704991 cites W2280404143 @default.
• W4386704991 cites W2502241587 @default.
• W4386704991 cites W2513943590 @default.
• W4386704991 cites W2527109340 @default.
• W4386704991 cites W2569998209 @default.
• W4386704991 cites W2892368225 @default.
• W4386704991 cites W3093891877 @default.
• W4386704991 cites W3193204579 @default.
• W4386704991 cites W4221043707 @default.
• W4386704991 cites W8509828 @default.
• W4386704991 doi "https://doi.org/10.1128/aac.00510-23" @default.
• W4386704991 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37702483" @default.
• W4386704991 hasPublicationYear "2023" @default.
• W4386704991 type Work @default.
• W4386704991 citedByCount "0" @default.
• W4386704991 crossrefType "journal-article" @default.
• W4386704991 hasAuthorship W4386704991A5002303307 @default.
• W4386704991 hasAuthorship W4386704991A5004871899 @default.
• W4386704991 hasAuthorship W4386704991A5006534529 @default.
• W4386704991 hasAuthorship W4386704991A5007757700 @default.
• W4386704991 hasAuthorship W4386704991A5008639301 @default.
• W4386704991 hasAuthorship W4386704991A5022751311 @default.
• W4386704991 hasAuthorship W4386704991A5025336363 @default.
• W4386704991 hasAuthorship W4386704991A5043849320 @default.
• W4386704991 hasAuthorship W4386704991A5051481287 @default.
• W4386704991 hasAuthorship W4386704991A5058736163 @default.
• W4386704991 hasAuthorship W4386704991A5067354013 @default.
• W4386704991 hasAuthorship W4386704991A5067747157 @default.
• W4386704991 hasAuthorship W4386704991A5079221259 @default.
• W4386704991 hasAuthorship W4386704991A5079585400 @default.
• W4386704991 hasAuthorship W4386704991A5081203939 @default.
• W4386704991 hasAuthorship W4386704991A5085225502 @default.
• W4386704991 hasAuthorship W4386704991A5088044766 @default.
• W4386704991 hasConcept C126322002 @default.
• W4386704991 hasConcept C17923572 @default.
• W4386704991 hasConcept C2776237055 @default.
• W4386704991 hasConcept C2776685102 @default.
• W4386704991 hasConcept C2779375183 @default.
• W4386704991 hasConcept C2779443120 @default.
• W4386704991 hasConcept C501593827 @default.
• W4386704991 hasConcept C64778159 @default.
• W4386704991 hasConcept C71924100 @default.
• W4386704991 hasConcept C77411442 @default.
• W4386704991 hasConcept C86803240 @default.
• W4386704991 hasConcept C89423630 @default.
• W4386704991 hasConcept C90924648 @default.
• W4386704991 hasConcept C94665300 @default.
• W4386704991 hasConceptScore W4386704991C126322002 @default.
• W4386704991 hasConceptScore W4386704991C17923572 @default.
• W4386704991 hasConceptScore W4386704991C2776237055 @default.
• W4386704991 hasConceptScore W4386704991C2776685102 @default.
• W4386704991 hasConceptScore W4386704991C2779375183 @default.
• W4386704991 hasConceptScore W4386704991C2779443120 @default.
• W4386704991 hasConceptScore W4386704991C501593827 @default.
• W4386704991 hasConceptScore W4386704991C64778159 @default.
• W4386704991 hasConceptScore W4386704991C71924100 @default.
• W4386704991 hasConceptScore W4386704991C77411442 @default.
• W4386704991 hasConceptScore W4386704991C86803240 @default.
• W4386704991 hasConceptScore W4386704991C89423630 @default.
• W4386704991 hasConceptScore W4386704991C90924648 @default.
• W4386704991 hasConceptScore W4386704991C94665300 @default.
• W4386704991 hasFunder F4320321945 @default.
• W4386704991 hasLocation W43867049911 @default.
• W4386704991 hasLocation W43867049912 @default.
• W4386704991 hasOpenAccess W4386704991 @default.
• W4386704991 hasPrimaryLocation W43867049911 @default.
• W4386704991 hasRelatedWork W1970948691 @default.
• W4386704991 hasRelatedWork W2326035127 @default.
• W4386704991 hasRelatedWork W2790937404 @default.
• W4386704991 hasRelatedWork W2801265347 @default.

• next